Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19

While looking for a solution to treat COVID-19, the massive off-label use of several drugs in COVID-19 has generated concerns in the early phase of the pandemic because of possible arrhythmogenic effects in relation to QTc interval prolongation. Indeed, some of these drugs have been historically ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiavone, Marco, Gasperetti, Alessio, Gherbesi, Elisa, Bergamaschi, Luca, Arosio, Roberto, Mitacchione, Gianfranco, Viecca, Maurizio, Forleo, Giovanni B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556572/
https://www.ncbi.nlm.nih.gov/pubmed/35221089
http://dx.doi.org/10.1016/j.ccep.2021.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556572/
https://www.ncbi.nlm.nih.gov/pubmed/35221089
http://dx.doi.org/10.1016/j.ccep.2021.10.009

Ejemplares similares